Upadacitinib Improves Giant Cell Arteritis in Phase 3 Trial
VIENNA — Results from the phase 3 SELECT-GCA study showed that the Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) induces significant ...
Read more
Tag: Upadacitinib
FDA Extends Upadacitinib Indications to Kids With Arthritis
Upadacitinib (Rinvoq) is now indicated for patients aged 2 years or older with active polyarticular juvenile idiopathic arthritis (pJIA) and ...
Read more
The Earth News is an independent English-language daily published Website from all around the World News